Insider · CIK 0001352455

Wasman Jane

CIK 0001352455 Name as filed on the most recent filing

Filed as Wasman Jane (43)

212 transaction lines · from 43 filings · filed 2006-11-08 to 2025-06-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

212 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-05-30 P, Open-market purchase Sellas Life Sciences Group, Inc.SLS 33,800, acquired Open Form 4 filing 0001104659-25-055495
2019-12-02 S, Open-market sale Acorda Therapeutics IncACOR 3,553, disposed Open Form 4 filing 0001209191-19-058939
2018-12-03 S, Open-market sale Acorda Therapeutics IncACOR 62,947, disposed Open Form 4 filing 0001209191-18-061119
2018-01-19 S, Open-market sale Acorda Therapeutics IncACOR 2 lines 952,319, disposed Open Form 4 filing 0001209191-18-004824
2017-12-01 S, Open-market sale Acorda Therapeutics IncACOR 93,662, disposed Open Form 4 filing 0001209191-17-063699
2017-02-09 S, Open-market sale Acorda Therapeutics IncACOR 1,216,218, disposed Open Form 4 filing 0001209191-17-009976
2016-12-01 S, Open-market sale Acorda Therapeutics IncACOR 2 lines 69,400, disposed Open Form 4 filing 0001209191-16-153415
2016-10-03 S, Open-market sale Acorda Therapeutics IncACOR 77,927, disposed Open Form 4 filing 0001209191-16-144914
2016-09-23 S, Open-market sale Acorda Therapeutics IncACOR 13,660, disposed Open Form 4 filing 0001209191-16-142858
2015-12-23 S, Open-market sale Acorda Therapeutics IncACOR 463,395, disposed Open Form 4 filing 0001209191-15-087015
2015-12-22 S, Open-market sale Acorda Therapeutics IncACOR 2 lines 585,432, disposed Open Form 4 filing 0001209191-15-086952
2015-12-21 S, Open-market sale Acorda Therapeutics IncACOR 34,314, disposed Open Form 4 filing 0001209191-15-086531
2015-12-17 S, Open-market sale Acorda Therapeutics IncACOR 131,080, disposed Open Form 4 filing 0001209191-15-086368
2015-12-01 S, Open-market sale Acorda Therapeutics IncACOR 210,294, disposed Open Form 4 filing 0001209191-15-083243
2015-10-05 S, Open-market sale Acorda Therapeutics IncACOR 2 lines 119,072, disposed Open Form 4 filing 0001209191-15-074443
2014-12-01 S, Open-market sale Acorda Therapeutics IncACOR 247,471, disposed Open Form 4 filing 0001209191-14-072920
2014-11-03 S, Open-market sale Acorda Therapeutics IncACOR 519,949, disposed Open Form 4 filing 0001209191-14-066631
2014-10-03 S, Open-market sale Acorda Therapeutics IncACOR 127,983, disposed Open Form 4 filing 0001209191-14-062336
2014-09-24 S, Open-market sale Acorda Therapeutics IncACOR 537,228, disposed Open Form 4 filing 0001209191-14-059967
2014-08-27 S, Open-market sale Acorda Therapeutics IncACOR 492,459, disposed Open Form 4 filing 0001209191-14-054908
2013-12-02 S, Open-market sale Acorda Therapeutics IncACOR 282,394, disposed Open Form 4 filing 0001209191-13-055281
2013-10-03 S, Open-market sale Acorda Therapeutics IncACOR 134,009, disposed Open Form 4 filing 0001209191-13-047575
2012-12-03 S, Open-market sale Acorda Therapeutics IncACOR 169,868, disposed Open Form 4 filing 0001209191-12-055901
2011-12-01 S, Open-market sale Acorda Therapeutics IncACOR 168,324, disposed Open Form 4 filing 0001209191-11-059460
2010-12-01 S, Open-market sale Acorda Therapeutics IncACOR 2 lines 198,994, disposed Open Form 4 filing 0001209191-10-058333
2009-12-01 S, Open-market sale Acorda Therapeutics IncACOR 122,507, disposed Open Form 4 filing 0001209191-09-055049
2008-12-01 S, Open-market sale Acorda Therapeutics IncACOR 39,950, disposed Open Form 4 filing 0001209191-08-063863
2008-06-11 S, Open-market sale Acorda Therapeutics IncACOR 9 lines 110,420, disposed Open Form 4 filing 0001179110-08-012127
2008-05-12 S, Open-market sale Acorda Therapeutics IncACOR 6 lines 46,341, disposed Open Form 4 filing 0001179110-08-009433
2008-02-11 S, Open-market sale Acorda Therapeutics IncACOR 29,509, disposed Open Form 4 filing 0001179110-08-003053
2008-02-11 S, Open-market sale Acorda Therapeutics IncACOR 11,520, disposed Open Form 4 filing 0001179110-08-003053
2008-02-11 S, Open-market sale Acorda Therapeutics IncACOR 9,389, disposed Open Form 4 filing 0001179110-08-003053

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 1
  • Open-market sale 211
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Wasman Jane, insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001352455

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.